Gland Pharma Ltd on Tuesday (February 25) announced that America's drug regulatory watchdog has completed a crucial inspection of its Andhra Pradesh facility. In a regulatory filing, Gland Pharma said ...
The US Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAI) for Sterile APIs at Gland Pharma’s facility at JNPC, Visakhapatnam between February 19 and February 25.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback